Efficacy, Safety, and Biomarkers of Toripalimab in Patients with Recurrent or Metastatic Neuroendocrine Neoplasms: A Multiple-Center Phase Ib Trial

Lu, M; Zhang, PP; Zhang, YQ; Li, ZW; Gong, JF; Li, J; Li, J; Li, Y; Zhang, XT; Lu, ZH; Wang, XC; Zhou, J; Peng, Z; Wang, WF; Feng, H; Wu, H; Yao, S; Shen, L

Shen, L (corresponding author), Peking Univ, Canc Hosp & Inst, Fu Cheng Rd 52, Beijing 100142, Peoples R China.

CLINICAL CANCER RESEARCH, 2020; 26 (10): 2337

Abstract

Purpose: Patients with recurrent or metastatic neuroendocrine neoplasms (NEN) had a poor prognosis and few treatment options. Toripalimab, a humanized......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索